v3.10.0.1

Stockholders' Equity | 9 Months Ended
--- | ---
Sep. 30, 2018
Stockholders' Equity Note [Abstract] |
Stockholders' Equity Note Disclosure [Text Block] |
| 9. | Stockholders’ Equity
Stock-Based Compensation On May 7, 2018, in connection with the closing of the sale under the APA of substantially all of the Company’s assets to Cellularity, which triggered certain change in control provisions of the Company’s equity plans, all unvested and outstanding options and restricted stock awards under the 2011 Plan and 2014 Plan became vested and exercisable. A summary of the stock option activity for the nine months ended September 30, 2018 is presented below (in thousands, except years and per option data):
|  | Number of O ptions |  |  | Weighted Average Exercise Price per Option |  |  | Weighted Average Remaining Life in Years |  |  | Intrinsic Value |
Outstanding, December 31, 2017 |  |  | 810 |  |  | $ | 52.90 |  |  |  |  |  |  |  |  |
Granted |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Forfeited |  |  | (466 | ) |  |  | 34.68 |  |  |  |  |  |  |  |  |
Outstanding, September 30, 2018 |  |  | 344 |  |  | $ | 46.54 |  |  |  | 4.8 |  |  | $ | - |
Exerciseable, September 30, 2018 |  |  | 344 |  |  | $ | 46.54 |  |  |  | 4.8 |  |  | $ | - |
As a result, a summary of the Company’s outstanding and exercisable options as of September 30, 2018 was as follows (in thousands, except per share data):
|  | Options Outstanding |  |  | Options Exercisable |  |  |  |
Range of ‎ Exercise Price |  | Weighted ‎ Average ‎ Exercise ‎ Price |  |  | Outstanding ‎ Number of ‎ Options |  |  | Weighted Average ‎ Exercise Price |  |  | Weighted ‎ Average ‎ Remaining ‎ Life in Years |  |  | Exercisable ‎ Number of ‎ Options |
$2.00 - $4.00 |  | $ | 3.63 |  |  |  | 54 |  |  |  | 3.63 |  |  |  | 8.4 |  |  |  | 54 |
$4.10 - $9.90 |  |  | 8.72 |  |  |  | 23 |  |  |  | 8.72 |  |  |  | 7.6 |  |  |  | 23 |
$10.00 - $19.90 |  |  | 10.77 |  |  |  | 11 |  |  |  | 10.77 |  |  |  | 5.8 |  |  |  | 11 |
$20.00 - $39.90 |  |  | 33.47 |  |  |  | 40 |  |  |  | 33.47 |  |  |  | 4.6 |  |  |  | 40 |
$40.00 - $49.90 |  |  | 44.71 |  |  |  | 27 |  |  |  | 44.71 |  |  |  | 4.0 |  |  |  | 27 |
$50.00 - $59.90 |  |  | 53.87 |  |  |  | 26 |  |  |  | 53.87 |  |  |  | 1.5 |  |  |  | 26 |
$60.00 - $69.90 |  |  | 66.23 |  |  |  | 135 |  |  |  | 66.23 |  |  |  | 4.2 |  |  |  | 135 |
$70.00 - $79.90 |  |  | 79.40 |  |  |  | 1 |  |  |  | 79.40 |  |  |  | 5.6 |  |  |  | 1 |
$80.00 - $89.90 |  |  | 87.50 |  |  |  | 11 |  |  |  | 87.50 |  |  |  | 2.9 |  |  |  | 11 |
$90.00 - $99.90 |  |  | 90.00 |  |  |  | 11 |  |  |  | 90.00 |  |  |  | 3.0 |  |  |  | 11 |
$100.00 - $266.90 |  |  | 109.40 |  |  |  | 5 |  |  |  | 109.40 |  |  |  | 1.6 |  |  |  | 5 |
|  |  | 46.54 |  |  |  | 344 |  |  |  | 46.54 |  |  |  | 4.8 |  |  |  | 344 |
For the three months ended September 30, 2018 and 2017, the Company recognized $0.023 million and $0.7 million of stock-based compensation expense, of which, $0.009 million and ($0.001) million is included in cost of revenues and $0.014 million and $0.7 million is included in selling, general and administrative expenses in the condensed consolidated statements of operations, respectively. For the nine months ended September 30, 2018 and 2017, the Company recognized $1.0 million and $1.6 million of stock-based compensation expense, of which, $0.030 million and $0.025 million is included in cost of revenues and $0.97 million and $1.6 million is included in selling, general and administrative expenses in the condensed consolidated statements of operations, respectively. As of September 30, 2018, there was no unrecognized stock-based compensation expense remaining. Reverse Stock Split The Company effected a 1-for-10 reverse stock split of its outstanding common stock on October 5, 2017. The accompanying consolidated financial statements and accompanying notes to the consolidated financial statements give retroactive effect to the reverse stock split for all periods presented. The shares of common stock retained a par value of $0.001 per share.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration